by nms-sync | Mar 4, 2023 | News
ACCELERA, a full-service Contract Research Organization collaborating with more than 350 Sponsors worldwide, offers complete IND-enabling packages.
Based on its huge expertise with both small and large molecules, ACCELERA offers tailored services spanning...
by nms-sync | Feb 8, 2023 | News
Accelera, Società insediata all’interno del vasto Campus biomedico di proprietà della holding NMS Group a Nerviano (MI), è una delle poche aziende italiane in grado di fornire supporto in tutte le fasi di ricerca e sviluppo del farmaco,...
by nms-sync | Jan 10, 2023 | News
Nerviano, 9 January 2023 NMS Group S.p.A. (NMS Group), the largest oncological R&D company in Italy, announces the appointment of Ms. Sidney Dung as Chief Operating Officer with immediate effect. Ms. Dung, currently a member of the Company’s Executive Leadership...
by nms-sync | Oct 1, 2022 | News
Accelera Srl Announces Change in Board Composition Effective Today
Nerviano_October_1_2022_Accelera Srl, leading CRO and a member of the NMS Group today announced the change in its Board Composition, following the resignation of its board member Enrico...
by Sidney | Sep 7, 2022 | Events, News
Dr. Simone Pollo main research interests are the ethics of human/animal relationships and the naturalization of ethics. He is MA in Philosophy at Sapienza University of Rome (1995) and PhD in Bioethics at the University of Genoa (2011). He is currently Associate...
by nms-sync | Jun 29, 2022 | News
The Board of Directors of NMS Group S.p.A has approved today the company’s annual financial report, including the consolidated financial statements of the Group as of 31 December 2021.
“2021 was a challenging yet rewarding year for our Group. As we firmly believe...
Welcome and Check out our new motion picture!
Recent Comments